Losaltan

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Losaltan

What is Losaltan? (Losartan Potassium)

Losaltan is a pharmaceutical preparation widely recognized for its systemic role in managing elevated blood pressure, characterized by its precise action on the body's vascular regulation system.


Quick Facts

Property Description
Active Ingredient Losartan potassium
Form Oral tablet (Film-coated)
Pharmacological Class Angiotensin II Receptor Blocker (ARB)
Common Purpose Systemic control of arterial blood pressure
Origin Synthetic compound

What Type of Medicine is Losaltan? (Identity and Classification)

Losaltan is the brand name for a medication whose active component is Losartan potassium, which is classified pharmacologically as an Angiotensin II Receptor Blocker (ARB), a dedicated antihypertensive agent. This drug is a wholly synthetic compound, a non-peptide tetrazole derivative, engineered to modulate systemic blood pressure. Losartan functions as a selective antagonist of the AT1 receptor, acting on vascular smooth muscle. This mechanism characterizes its role in cardiovascular medicine through the blockade of the AT1 receptor. The medication is generally supplied as a single-ingredient product, though established combination formulations with diuretic agents are also recognized pharmaceutical preparations.

Losartan's Primary Form and Composition

Losaltan is supplied as an oral tablet, the standard dosage form designed for systemic administration through ingestion. The therapeutic effect is derived from the salt Losartan potassium. Losartan is a prodrug that is converted by the liver into an active, more potent metabolite, which contributes to the drug's effectiveness over a 24-hour period. The tablets include necessary inert excipients, such as microcrystalline cellulose, which serve as the structural base/vehicle for stable drug delivery.

What is the General Goal of Losaltan? (High-Level Purpose)

Losaltan's core function is to lower and maintain control over arterial blood pressure by reducing the resistance blood encounters in the vascular network. It achieves this through AT1 receptor antagonism, preventing the vasoconstrictor hormone Angiotensin II from binding to its specific receptor site. This blocking action promotes vasodilation (vessel widening), which decreases the overall peripheral vascular resistance, supporting the functioning of the cardiovascular system. Losartan is also characterized by a uricosuric effect, which involves the excretion of uric acid, a physiological feature recognized alongside its blood pressure regulation properties.

Regulatory References

  1. Losartan: MedlinePlus Drug Information

What side effects are possible with Losaltan?

Possible Side Effects and Safety Information

Losaltan's safety profile is officially documented and classified by regulatory authorities, detailing potential adverse reactions according to their frequency and the body system affected. These classifications are based on findings from clinical trials and post-marketing experience.

Frequency-Classified Adverse Reactions

Adverse reactions are formally categorized based on their observed incidence:

Frequency Classification Documented Reactions (Examples)
Common (occurring in ge 1/100 to < 1/10) Dizziness, headache, upper respiratory infection, fatigue.
Uncommon (occurring in ge 1/1,000 to < 1/100) Vertigo, somnolence, palpitations, rash, constipation, or diarrhea.
Rare (occurring in ge 1/10,000 to < 1/1,000) Hypersensitivity reactions, including angioedema.

System-Organ-Class Safety Notes

The documented effects are grouped by body system, including Nervous System Disorders, Vascular Disorders (e.g., symptomatic hypotension), Gastrointestinal Disorders, and Skin and Subcutaneous Tissue Disorders. There are also notes concerning Metabolism and Nutrition Disorders, specifically the potential for Hyperkalemia (elevated potassium levels).

Serious Adverse Reactions and Constraints

Serious adverse reactions documented in regulatory labeling include Angioedema (swelling of the face, lips, and throat), Anaphylactic Reactions, and potential for severe outcomes such as Renal Failure in susceptible patients. Hypotension is explicitly noted as being more frequent at the start of treatment or during dose adjustment. Losaltan is contraindicated for use during the second and third trimesters of pregnancy due to documented risks of fetal injury and death. Specific caution is required for patients with severe hepatic impairment or bilateral renal artery stenosis.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdosage with Losaltan (Losartan Potassium) is documented in official regulatory sources to result from an exaggeration of the drug's pharmacological effect, predominantly on the cardiovascular system. The clinical manifestations most frequently listed are hypotension (excessive low blood pressure) and changes in heart rate, which may present as tachycardia (increased heart rate) or, less frequently, bradycardia (decreased heart rate). The most severe outcome requiring intervention is symptomatic hypotension.

In the event of a suspected overdose, regulatory guidance strictly mandates that individuals seek immediate medical attention and contact a regional poison control center immediately. Contacting emergency services is required for severe presentations such as collapse or loss of consciousness.

Management in a clinical setting is defined as symptomatic and supportive. The official product information specifies that no specific antidote is known for Losaltan. Furthermore, the drug and its active metabolite are documented as not removable by hemodialysis due to their strong protein-binding properties. Supportive care may involve measures to correct fluid volume or salt depletion.

Therapeutic Uses of Losaltan

Main Uses of Losartan

Losartan is a medication belonging to a class of drugs known as angiotensin II receptor blockers (ARBs). It is primarily utilized to manage cardiovascular conditions by helping to relax blood vessels, which facilitates easier blood flow and reduces the workload on the heart.

Management of Hypertension

The primary use of losartan is the treatment of high blood pressure, also known as hypertension. By blocking the action of angiotensin II—a natural substance in the body that causes blood vessels to tighten—losartan helps the vessels remain dilated. Maintaining blood pressure within a healthy range is essential for reducing the long-term risk of serious health complications.

Kidney Protection in Diabetic Patients

Losartan is frequently used to treat nephropathy (kidney disease) in individuals with type 2 diabetes who also have a history of hypertension. In these patients, the medication helps to slow the progression of kidney damage. It works by reducing the pressure within the filtering units of the kidneys, which can help decrease the amount of protein leaked into the urine.

Stroke Risk Reduction

For patients with hypertension and a specific heart condition called left ventricular hypertrophy (an enlargement of the walls of the heart's main pumping chamber), losartan is used to reduce the risk of stroke. While it is effective for this purpose in many populations, clinical data suggests this benefit may vary based on individual health factors and background.

Benefits of Treatment

  • Cardiovascular Health: By lowering systemic blood pressure, the medication reduces the strain on the heart and arteries.
  • Organ Preservation: Through its action on blood pressure and vascular resistance, it helps protect vital organs, particularly the kidneys and the heart, from the chronic effects of hypertension.
  • Long-term Risk Management: Consistent management of blood pressure with medications like losartan is a key component in lowering the likelihood of experiencing heart attacks or strokes over time.

Regulatory References

  1. FDA official labeling via NIH DailyMed

Eligibility and Restrictions for Use

Losaltan (Losartan potassium) eligibility is strictly defined by regulatory criteria, governing who may use the medicine and who is formally prohibited from doing so. The following official statements determine patient suitability:


Contraindicated Populations

Losaltan is formally contraindicated (must not be used) in patients with the following conditions or states, as per official labeling:

  • Known hypersensitivity to losartan or any component.
  • Second and third trimesters of pregnancy (discontinuation is required immediately upon detection of pregnancy).
  • Severe hepatic impairment (severe liver disease).
  • Concomitant use with Aliskiren in patients with Diabetes Mellitus or with renal impairment (GFR <60 mL/min/1.73 m^2).

Conditional Use and Age Rules

Classification Population/Condition Restriction/Limitation
Approved Age Children and Adolescents Approved for hypertension in patients 6 to 18 years of age [Source 2.3].
Not Recommended Children under 6 years Safety and efficacy have not been established [Source 2.3].
Conditional Use Mild to Moderate Hepatic Impairment Use with caution; a lower starting dose is recommended [Source 1.5].
Conditional Use Volume- or Salt-Depleted Patients Condition must be corrected prior to initiation of therapy [Source 2.1].
Not Recommended Breastfeeding/Lactation Not recommended, especially when nursing a newborn or preterm infant [Source 2.5].

The eligibility profile is structured around definitive contraindications and conditional use rules, establishing the boundaries of safe use documented in government-approved prescribing information.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Losaltan (Losartan potassium) interaction patterns are officially documented by regulatory authorities, focusing on pharmacokinetic and pharmacodynamic outcomes.

Contraindicated Combinations and Restrictions

Co-administration with Aliskiren is contraindicated in patients with Diabetes Mellitus and generally avoided in those with significant Renal Impairment (GFR less than 60 mL/min). Furthermore, Losaltan is contraindicated in patients with Severe Hepatic Impairment due to significantly altered drug clearance, which results in up to a five-fold increase in Losaltan plasma concentrations.

Pharmacodynamic and Substance Interactions

Concurrent use with agents that affect serum potassium balance, such as Potassium-sparing diuretics (e.g., Spironolactone, Triamterene) and Potassium Supplements/Salt Substitutes, increases the additive risk of Hyperkalemia. The co-administration of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including COX-2 Inhibitors, may lead to an increased risk of Renal Impairment and can attenuate the antihypertensive effect. Additionally, Lithium clearance is reduced, increasing the risk of Lithium toxicity.

Pharmacokinetic Exposure Alterations

Interactions involving the CYP2C9 enzyme system are officially documented. The CYP2C9 inhibitor Fluconazole is noted to increase the systemic exposure of Losaltan while decreasing the exposure of the active metabolite. Conversely, Rifampin and Phenobarbital, which are inducers, result in a documented reduction in the systemic exposure of both Losaltan and its active metabolite.

Mechanism of Action

How Losaltan Works

Losaltan's mechanism of action centers on the Angiotensin II Type 1 ( AT1) receptor. The compound and its active metabolite ( EXP3174) act as AT1 receptor antagonists, competitively and non-competitively preventing the hormonal mediator Angiotensin II from binding to its receptor. This targeted blockade interrupts the primary effector pathway of the Renin-Angiotensin System ( RAS) .

This antagonism eliminates the molecular signal for vascular smooth muscle contraction, leading to vasodilation and a reduction in total peripheral resistance to blood flow. Additionally, the mechanism dampens the Angiotensin II-driven hormonal signal for aldosterone release, which affects sodium and water reabsorption in the kidneys, thereby modulating fluid volume within the circulatory system.

Separately, Losaltan exerts a secondary action by acting as an inhibitor of the Urate Transporter 1 ( URAT1) in the renal proximal tubule. Blocking this transporter interferes with the reabsorption of filtered uric acid, leading to increased uric acid excretion, a functional consequence known as the uricosuric effect.

Dosage and Administration Information

How to Use Losartan: Official Administration Guidelines

Losartan is prescribed as an oral tablet that must be swallowed whole with water. This medication is typically taken once daily, and administration should occur at approximately the same time each day to maintain consistent levels in the body. The tablet may be taken with or without food.


Dosing Instructions for Specific Patient Groups

Patient Group Recommended Starting Dose
Most Adults 50 mg once daily
Patients with Hepatic Impairment (Mild-to-moderate) 25 mg once daily
Patients with Possible Intravascular Volume Depletion 25 mg once daily
Children (6 to 16 years) 0.7 mg/kg once daily (up to 50 mg total)

Dosage is individual and may be adjusted by a healthcare provider, with the usual maximum dose being 100 mg once daily. A lower starting dose of 25 mg once daily is specifically documented for adult patients with mild-to-moderate liver problems or for those who may be volume-depleted, such as patients already receiving high-dose diuretics.

Procedural Steps for Missed Doses

If a dose is missed, it should be taken as soon as possible. However, if it is almost time for the next scheduled dose, the missed dose must be skipped to avoid taking a double dose. Patients must then return to their regular administration schedule. For pediatric patients, the drug may be administered as a tablet or a prepared oral suspension based on the prescribed dose.

Recent Clinical Evidence

Losaltan: Recent Clinical Evidence

Losaltan, an angiotensin II receptor blocker (ARB), has been the subject of extensive clinical research primarily focusing on its use in hypertension (high blood pressure) and heart failure.


Efficacy in Major Cardiovascular Outcomes

Clinical trial results support Losaltan's role in reducing the risk of major cardiovascular events. The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) study found that in patients with hypertension and left ventricular hypertrophy (enlargement of the heart's main pumping chamber), Losaltan-based therapy, compared to Atenolol-based therapy, was associated with a greater reduction in the combined risk of cardiovascular death, heart attack, or stroke. This difference was largely driven by a significantly lower rate of stroke in the Losaltan group.


Evidence in Heart Failure and Kidney Protection

  • Heart Failure (HF): Studies such as the HEAAL (Heart failure Endpoint evaluation of Angiotensin II Antagonist Losartan) study investigated high-dose Losaltan (150 mg/day) versus low-dose (50 mg/day) in patients with heart failure who could not tolerate ACE inhibitors. The higher dose was associated with a greater reduction in the combined risk of death or hospitalization for heart failure.
  • Kidney Function: Losaltan has been investigated for its renoprotective effects in patients with type 2 diabetes and established kidney disease (diabetic nephropathy). Evidence indicates that Losaltan use is associated with preserving kidney function by helping to reduce proteinuria (protein in the urine), which is a marker of kidney damage.

Safety and Tolerability

Across multiple large-scale clinical trials, Losaltan demonstrated a generally favorable tolerability profile. The most commonly reported side effects include dizziness and headache. In comparative trials, the rate of patient withdrawal due to cough was substantially lower for Losaltan compared to the ACE inhibitor Captopril, supporting its use as an alternative therapy for patients who experience cough on ACE inhibitors.

Key Studies & References

  1. WHO Model List of Essential Medicines - Losartan

Frequently Asked Questions (FAQ)

Common questions about Losaltan (FAQ)

Q: How quickly does Losaltan start working after I take the first pill?

A: The initial blood pressure-lowering effect of Losaltan is typically observed within approximately two hours after taking the first dose. However, the official product information indicates that the full or maximal intended effect in controlling blood pressure is generally achieved over a longer period, usually three to six weeks of consistent daily use.

Q: What happens if you miss a dose of Losaltan?

A: Official guidance describes that if a dose is missed, it should be taken as soon as possible. However, if it is nearly time for your next regularly scheduled dose, the missed dose is generally skipped to avoid taking a double amount of the medicine.

Q: Can Losaltan affect kidney function?

A: Losaltan's effects on kidney function are documented as having a dual nature. In patients with Type 2 Diabetes and established kidney disease, Losaltan is associated with a kidney-preserving effect. Conversely, official warnings also note a potential risk of renal impairment (kidney damage) when Losaltan is used concurrently with certain medications, such as Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).

Q: Is it true that Losaltan can protect the kidneys?

A: Evidence indicates that Losaltan's use in treating kidney disease specifically associated with Type 2 Diabetes (diabetic nephropathy) is associated with preserving kidney function. This is seen by helping to reduce the amount of protein that passes into the urine.

Q: If I have a history of angioedema, is Losaltan still an option?

A: Losaltan, like other Angiotensin II Receptor Blockers (ARBs), is associated with a risk of angioedema, which is serious swelling of the face, lips, and throat. Official warnings note that patients who have a history of this reaction after taking an ACE inhibitor medicine may have an increased risk of angioedema when taking Losaltan.

Q: Is Losaltan a water pill (diuretic)?

A: No. Losaltan is formally classified as an Angiotensin II Receptor Blocker (ARB), which works by blocking a specific hormone in the body. It is not a diuretic (water pill). Losaltan is sometimes manufactured as a combination product with a diuretic for patients who need both types of medication.

Q: Does Losaltan cause weight gain or loss?

A: Weight changes (gain or loss) are not listed as a common or rare side effect in official regulatory documents. However, a documented adverse reaction is edema (swelling or fluid retention), which may lead to temporary changes in body weight.

Q: Can Losaltan affect sleep?

A: Insomnia (difficulty sleeping) is listed in official product information as a common side effect. Other sleep-related issues, such as general sleep disorder, are also documented but are reported with less frequency.

Q: Are there any foods or drinks to avoid while taking Losaltan?

A: Official warnings primarily focus on the use of potassium supplements and salt substitutes that contain potassium. This is because Losaltan can affect potassium levels, and combining it with these products may lead to high blood potassium (hyperkalemia).

Q: What is the evidence or research showing Losaltan's effect on heart health?

A: Clinical studies summarized in official documents show that Losaltan-based therapy is associated with a reduction in the combined risk of serious events like cardiovascular death, heart attack, or stroke in certain patients with high blood pressure and an enlarged heart. Losaltan has also been studied for its use in managing heart failure.

Q: Can Losaltan be split or crushed?

A: The official administration instructions state that the Losaltan tablet should be swallowed whole. While some tablets may have a score line allowing for division into equal doses, they are documented to be swallowed whole as a general administration instruction.

Q: Is Losaltan the same as the generic version?

A: Losaltan is the brand name for the active chemical ingredient, which is Losartan potassium. The generic version of the medicine contains the identical active ingredient and must meet the same regulatory standards for quality and effectiveness.

Q: Does Losaltan have a risk of addiction?

A: Official sources confirm that Losaltan is not classified as a controlled substance by regulatory bodies like the U.S. Drug Enforcement Administration. It is not considered a drug with a potential for abuse or addiction.

Q: Why is Losaltan sometimes prescribed for people with diabetes?

A: Losaltan is prescribed for people with Type 2 Diabetes who also have established kidney disease, a condition known as diabetic nephropathy. This is because official evidence supports its use in this population to help preserve kidney function.

Q: Can Losaltan cause changes in mood?

A: Changes in mood are not listed as a common side effect in official documents. However, adverse reactions in the psychiatric category, such as anxiety and depression, have been reported by patients, although the frequency of these events is generally uncommon or not precisely known.

Q: Is there a maximum amount of time a person can take Losaltan?

A: Official documents do not set a specific maximum duration of use. Losaltan is generally prescribed for the long-term management of chronic cardiovascular conditions. Studies have shown that the drug does not accumulate in the body upon repeated once-daily dosing.

Q: How long does it take for the full effect of Losaltan to be reached?

A: The maximum antihypertensive effect, meaning the most stable and controlled blood pressure level, is generally achieved after three to six weeks of consistent therapy. While the initial effect is rapid, the full therapeutic benefit develops over this longer time period.

Q: Can Losaltan interact with herbal supplements?

A: Official warnings highlight potential interactions with agents that affect potassium levels in the blood. If an herbal supplement is known to raise potassium levels, there is a potential concern for an interaction, which could lead to hyperkalemia (high blood potassium).

Q: Do studies suggest that Losaltan is effective in diverse populations?

A: Official labeling for Losaltan, when used to reduce the risk of stroke in patients with hypertension and an enlarged heart, notes that the observed benefit in the clinical trial did not apply to Black patients.

Q: What is the difference between Losaltan and Losaltan HCTZ?

A: Losaltan contains only the single active ingredient, Losartan potassium. Losaltan HCTZ is a fixed-dose combination product that contains Losartan potassium along with a second drug, hydrochlorothiazide, which is a type of diuretic.

Q: Does Losaltan help prevent strokes?

A: Clinical trial evidence summarized in official documents indicates that Losaltan-based therapy is associated with a significantly lower rate of stroke in patients with high blood pressure and an enlarged heart when compared to treatment with another blood pressure medication.

Q: Can Losaltan cause blurry vision?

A: Blurred vision is listed as a potential adverse reaction in official product information. This effect has been reported, although its frequency is generally uncommon or has not been definitively established in large-scale clinical trials.

Q: What types of medications are known to interact with Losaltan?

A: Official warnings detail interactions involving substances that may increase potassium levels, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), the drug Lithium, and certain drugs that affect the CYP2C9 liver enzyme.

Q: Why do doctors prescribe Losaltan for some kidney conditions?

A: Losaltan is prescribed for specific kidney conditions in patients with Type 2 Diabetes because the drug’s action in modulating the body’s vascular system is linked to a kidney-preserving effect. This effect is supported by evidence showing it reduces the amount of protein in the urine, a sign of kidney damage.

Q: Are there different strengths of Losaltan available?

A: Yes. Losaltan is supplied as an oral tablet and is officially available in several different dosage strengths. Common strengths documented in product information include 25 mg, 50 mg, and 100 mg tablets.

Q: What is the chemical name for Losaltan?

A: The active ingredient is Losartan potassium. The full chemical name is defined in official documents as 2-butyl-4-chloro-1-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]imidazole-5-methanol monopotassium salt.

Q: How is Losaltan different from a calcium channel blocker?

A: Losaltan is classified as an Angiotensin II Receptor Blockers (ARB), which works by blocking a hormone called Angiotensin II. Calcium Channel Blockers (CCBs) are a different class of medicine that works by interfering with the movement of calcium into the muscle cells of the heart and blood vessels.

Q: Are there any specific safety warnings related to Losaltan?

A: Yes. Key safety warnings documented in official labeling include the potential for severe reactions like Angioedema (swelling), the risk of Fetal Toxicity (it is contraindicated in the 2nd and 3rd trimesters of pregnancy), and the risk of Hyperkalemia (high potassium levels in the blood).

Q: Does Losaltan cause problems with swelling or fluid retention?

A: Edema (swelling) is listed as a documented adverse reaction in official product information. This effect has been reported by patients, sometimes specifically as facial swelling, and is associated with the action of the drug's active metabolite.

How should Losaltan be stored and disposed of?

How to Store and Dispose of Losartan

Official labeling defines specific conditions to maintain the stability of Losartan Potassium tablets.


Storage Requirements

Losartan tablets must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F), with permitted excursions up to 30 C. The medication requires protection from light and must be kept in a tightly closed container.

  • Oral Suspension: When prepared, the liquid suspension requires refrigeration at 2 C to 8 C and must be discarded after four weeks.
  • Child Safety: All forms of the product must be stored out of the sight and reach of children.

Disposal Instructions

Expired or unused Losartan must be disposed of according to professional instruction. Official regulatory documents advise asking a pharmacist or healthcare provider how to properly discard the medicine. Disposal via wastewater or household trash is prohibited unless otherwise instructed by a healthcare professional.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Losaltan found in:

A-Z Index: